Croise Pharma Private Limited
About Croise Pharma Private Limited
Data last updated:
Croise Pharma Private Limited is a private limited company based in Delhi, India. It operates in the manufacturing segment of the chemicals sector. It was incorporated on 19 May 2008 and has been in existence for over 18 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24232DL2008PTC178319. The company has 1 GST registration on record, which is no longer active.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Vineet Mittal and Rajeev Kumar Mittal.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 2062 – L Narela Mandi, Delhi, India – 110040.
As per the financials filed for FY 2025, the company reported a revenue of ₹10,000. For the same year it recorded a net loss of ₹249 (net margin -2.5%) and EBITDA of ₹400 (EBITDA margin 4%).
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Croise Pharma Private Limited's registered office is in Delhi, Delhi. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address2062 – L Narela Mandi, Delhi, India – 110040
- IndustryChemicals, Manufacturing, Other Chemical Product
To see the full contact details of Croise Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Croise Pharma Private Limited
FY 2025 filings availableCroise Pharma Private Limited reported revenue of ₹10,000 for FY 2025.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹400 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹249 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 4% | ||||
| Net Profit Margin | -2.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Croise Pharma Private Limited, buy the company report.
Board of directors of Croise Pharma Private Limited
Croise Pharma has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Vineet Mittal | Director | 19 May 2008 | 18 Years 5 Months | Current |
| Rajeev Kumar Mittal | Director | 19 May 2008 | 18 Years 5 Months | Current |
Auditor
Croise Pharma Private Limited is audited by VIKAS SACHIN & ASSOCIATES for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| VIKAS SACHIN & ASSOCIATES | FY 2017 | 014301C |
Shareholding
The shareholding of Croise Pharma Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Croise Pharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Croise Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Croise Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Croise Pharma has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
To see the full GST registrations and return filing status of Croise Pharma Private Limited, buy the company report.
Recent activity
Croise Pharma Private Limited has 2 board changes on record since 2008: 2 appointments. The latest: Rajeev Kumar Mittal was appointed as Director on 19 May 2008.
Frequently asked questions
Croise Pharma is an active private limited company based in Delhi, India. The company works in manufacturing, within the chemicals industry. It was incorporated on 19 May 2008 (18+ years old) and is registered under CIN U24232DL2008PTC178319.
Croise Pharma has 2 current directors:
- Vineet Mittal - Director
- Rajeev Kumar Mittal - Director
The latest financial statements of Croise Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
No. Croise Pharma has 1 GST registration on record and it is cancelled or inactive.
The CIN (Corporate Identification Number) of Croise Pharma is U24232DL2008PTC178319. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Croise Pharma was incorporated on 19 May 2008, making it 18+ years old. It is registered with the Registrar of Companies, Delhi.
Rajeev Kumar Mittal was appointed as Director on 19 May 2008. Vineet Mittal was appointed as Director on 19 May 2008.
The registered office of Croise Pharma is at 2062 – L Narela Mandi, Delhi, India – 110040.
Croise Pharma operates in the chemicals industry, in the manufacturing segment.
The compliance status of Croise Pharma is compliant as of 09 July 2026. The company is actively filing with the Registrar of Companies.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
